Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation
- 24 June 2008
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 128 (3), 224-232
- https://doi.org/10.1016/j.jconrel.2008.03.013
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A newly developed oral heparin derivative for deep vein thrombosis: Non-human primate studyJournal of Controlled Release, 2007
- Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight HeparinJournal of Pharmaceutical Sciences, 2007
- NanoCipro encapsulation in monodisperse large porous PLGA microparticlesJournal of Controlled Release, 2007
- The rejuvenated pressurised metered dose inhalerExpert Opinion on Drug Delivery, 2007
- Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparinJournal of Controlled Release, 2006
- Inhaled insulin is approved in Europe and United StatesBMJ, 2006
- Cationic stearylamine-containing biodegradable microparticles for DNA deliveryJournal of Microencapsulation, 2004
- Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric NanoparticlesDrug Delivery, 2001
- Inhalation of Estradiol for Sustained Systemic DeliveryJournal of Aerosol Medicine, 1999
- Relationship between Plasma Antifactor Xa Activity and the Antithrombotic Activity of Heparins of Different Molecular MassPathophysiology of Haemostasis and Thrombosis, 1995